<p>PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer</p>

Xiao Fu(First Affiliated Hospital of Xi'an Jiaotong University), Yu Yao(Central South University), Xiaoqiang Zheng(Fujian Medical University), Zhiping Ruan(Harvard University), Aimin Jiang(First Affiliated Hospital of Xi'an Jiaotong University), Na Liu(First Affiliated Hospital of Xi'an Jiaotong University), Jingjing Wang(Beijing Xuanwu Traditional Chinese Medicine Hospital), Mengjie Liu(First Affiliated Hospital of Xi'an Jiaotong University), Huan Gao(Westlake University), Xuan Liang(First Affiliated Hospital of Xi'an Jiaotong University), Yujuan Yang(Shanghai University), Zhiyan Liu(Northwest University), Luochengling Xiang(First Affiliated Hospital of Xi'an Jiaotong University), Tao Tian(Shandong University)
Cancer Management and Research
October 1, 2020
10.2147/cmar.s260599
Cited by 14

Related Papers

RETRACTED ARTICLE: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway
|Journal of Experimental & Clinical Cancer Research|2018|222
Micro<scp>RNA</scp>‐155‐5p promotes hepatocellular carcinoma progression by suppressing <scp>PTEN</scp> through the <scp>PI</scp>3K/Akt pathway
|Cancer Science|2017|166
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110
Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring
|Annals of Hematology|2010|100
miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer
|Oncology Reports|2015|84